Surgical Management of Enterocutaneous Fistulas

Indications for Surgery

High-output fistulas (>500 ml/day) are an indication for surgery, as they cannot be controlled medically, according to the American College of Surgeons 1, 2
Fistulas associated with bowel stricture or abscess require surgical intervention, as recommended by the American Society of Colon and Rectal Surgeons 1, 2
Failure of conservative management after adequate medical optimization is an indication for surgery, as stated by the Society of Surgical Oncology 1, 2
Complex fistulas with multiple tracts that reduce healing rates with anti-TNF therapy may require surgical intervention, according to the Crohn's and Colitis Foundation 1, 2
Postoperative fistulas, where medical therapy is unlikely to help, may require surgical repair, as recommended by the American College of Surgeons 1

Delaying surgery for 3-12 months after initial diagnosis or previous laparotomy allows for lysis of fibrous adhesions and improves outcomes, as stated by the Society of Surgical Oncology 1, 2
A four-step preparation protocol, including fluid and electrolyte balance, sepsis control, nutritional optimization, and skin care, is essential for successful surgery, according to the American Society of Colon and Rectal Surgeons 1, 2
Fluid and electrolyte balance can be achieved through aggressive IV resuscitation with normal saline (2-4 L/day) and replacement of sodium losses, as recommended by the American College of Surgeons 1, 2
Sepsis control involves treating abscesses with IV antibiotics and radiological drainage, followed by surgical drainage if necessary, as stated by the Infectious Diseases Society of America 3, 4, 1
Nutritional optimization, including parenteral nutrition for proximal or high-output fistulas and enteral nutrition for distal or low-output fistulas, is crucial for surgical success, according to the American Society for Parenteral and Enteral Nutrition 1, 2
Skin care, including protection of peristomal skin with barrier products and negative pressure wound therapy, is essential for preventing breakdown and complicating surgical planning, as recommended by the Wound, Ostomy, and Continence Nurses Society 2

Complete fistula tract excision with resection of involved bowel segment is a key operative principle, as stated by the American Society of Colon and Rectal Surgeons 3, 4
Primary anastomosis in healthy, well-vascularized bowel after adequate debridement is recommended, according to the American College of Surgeons 3, 4
Avoiding multiple strictureplasties in close proximity and instead performing a single resection is preferable if adequate bowel length remains, as stated by the Crohn's and Colitis Foundation 3, 4
Diverting ostomy may be necessary for complex cases or when primary anastomosis is high-risk, according to the American Society of Colon and Rectal Surgeons 5

Attempting anti-TNF therapy first for Crohn's disease-related fistulas associated with active inflammation is recommended, as stated by the Crohn's and Colitis Foundation 3, 4, 1
Only one-third of patients with Crohn's disease-related fistulas achieve fistula healing with anti-TNF therapy, according to the American Gastroenterological Association 1, 2
Complexity and stenosis reduce medical therapy success, and surgery may be necessary earlier in these cases, as recommended by the American Society of Colon and Rectal Surgeons 1, 2
Controlling proctitis medically before and after surgery is essential for preventing recurrence, according to the American Gastroenterological Association 5

Never starting anti-TNF therapy before draining abscesses can worsen sepsis, as stated by the Infectious Diseases Society of America 1, 2
Never operating immediately without nutritional optimization and sepsis control can lead to poor outcomes and high mortality, according to the American College of Surgeons 1, 2
Never neglecting skin care can cause significant additional morbidity and complicate surgical planning, as recommended by the Wound, Ostomy, and Continence Nurses Society 2
Never operating during active inflammation in Crohn's disease can lead to poor outcomes, and medical control of the disease is necessary first, according to the Crohn's and Colitis Foundation 5

Magnetic resonance imaging (MRI) is recommended as the first‑line imaging modality to delineate fistula anatomy, tract complexity, and to detect associated abscesses or bowel strictures. The high sensitivity and specificity of MRI for enteric fistulas surpasses that of alternative imaging techniques. 6
Fistula output should be classified by volume to guide nutritional strategy and predict the need for surgery: low output < 200 mL/day, moderate output 200–500 mL/day, and high output > 500 mL/day. This classification informs management decisions. 7

Aggressive intravenous fluid resuscitation (2–4 L/day of isotonic saline) is advised for high‑output fistulas to prevent severe dehydration and electrolyte loss.

Imaging must be used to identify intra‑abdominal abscesses, which should be drained before initiating anti‑TNF therapy or definitive surgery. 8
Abscesses are treated with appropriate intravenous antibiotics (e.g., metronidazole and/or ciprofloxacin) combined with percutaneous drainage when feasible. 7
Anti‑TNF agents must not be started until adequate abscess drainage has been achieved, as premature use can exacerbate sepsis. 8

High‑output (>500 mL/day) or proximal fistulas warrant early total parenteral nutrition (TPN); distal, low‑output colonic fistulas may be managed with enteral nutrition using short‑peptide formulas.

Application of barrier products and, when indicated, negative‑pressure wound therapy are recommended to protect peristomal skin from excoriation caused by fistula output. 7

Anti‑TNF therapy should be initiated only when the fistula is associated with active Crohn’s disease inflammation and all abscesses have been adequately drained. 8
Approximately one‑third of Crohn’s disease patients achieve fistula healing with anti‑TNF agents. 8
Medical therapy is generally ineffective for postoperative fistulas that develop within 30 days of surgery. 8
Fistulas with multiple tracts or concomitant stenosis have lower response rates to medical therapy and a higher likelihood of requiring surgical intervention. 8

Surgery is strongly indicated for:
- High‑output fistulas (>500 mL/day) that cannot be controlled medically.
- Fistulas associated with bowel stricture or intra‑abdominal abscess.
- Fistulas causing diarrhea and/or malabsorption. 7
When disease is localized to less than one‑third of the colon, resection should be limited to the affected segment. 7

All patients with colocutaneous fistulas should be managed by a multidisciplinary team—including gastroenterology, colorectal surgery, dietetics, and wound‑care specialists—to optimize outcomes. 8